ArticleOncology letters2014

Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling.

Jun DU et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.